p16INK4a/CDKN2A Antibody, DyLight 350, Novus Biologicals™
Manufacturer: Novus Biologicals
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | NB106490-Each-of-1 | In Stock | ₹ 41,207.00 |
NB106490 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 41,207.00
GST (18%): ₹ 7,417.26
Total Price: ₹ 48,624.26
Antigen
p16INK4a/CDKN2A
Classification
Polyclonal
Formulation
50 mM Sodium Borate
Host Species
Rabbit
Purification Method
Antigen Affinity-purified
Regulatory Status
RUO
Primary or Secondary
Primary
Target Species
Human
Form
Purified
Applications
Western Blot, Immunofluorescence
Conjugate
DyLight 350
Gene Alias
ARF, CDK4 inhibitor p16-INK4, CDK4IP14ARF, CDKN2, cell cycle negative regulator beta, CMM2P16-INK4A, Cyclin-dependent kinase 4 inhibitor A, cyclin-dependent kinase inhibitor 2A, cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4), INK4, INK4A, MLMP16INK4, MTS-1, MTS1P14, Multiple tumor suppressor 1, p14, p14ARF, p16, p16-INK4, p16INK4a, p16-INK4a, P19, p19ARF, TP16
Immunogen
Produced in rabbits immunized with a synthetic peptide corresponding to the C-terminus of human p16INK4a/CDKN2A.
Quantity
0.1 mL
Research Discipline
ABC Transporters, Biologically Active Proteins, Cancer, Cell Cycle and Replication, DNA Repair, Hypoxia, MAP Kinase Signaling, Neuroscience, Tumor Suppressors
Gene ID (Entrez)
1029
Content And Storage
Store at 4°C in the dark.
Isotype
IgG
Related Products
Description
- Description p16INK4a/CDKN2A Polyclonal specifically detects p16INK4a/CDKN2A in Human samples
- It is validated for Western Blot, Immunocytochemistry/Immunofluorescence.